Synapse

← Lung Cancer Targets and Therapy

Papers in Lung Cancer Targets and Therapy

Page 3 · newest first

  1. Detection of ROS1 rearrangement in non-small cell lung cancer: current and future perspectivesLung Cancer Targets and Therapy · 2017
  2. Spotlight on ramucirumab in the treatment of nonsmall cell lung cancer: design, development, and clinical activityLung Cancer Targets and Therapy · 2017
  3. Psychosocial challenges for patients with advanced lung cancer: interventions to improve well-beingLung Cancer Targets and Therapy · 2017
  4. A pilot study of zoledronic acid in the treatment of patients with advanced malignant pleural mesotheliomaLung Cancer Targets and Therapy · 2017
  5. Exhaled breath analysis for the early detection of lung cancer: recent developments and future prospectsLung Cancer Targets and Therapy · 2017
  6. Pembrolizumab in the treatment of metastatic non-small-cell lung cancer: patient selection and perspectivesLung Cancer Targets and Therapy · 2017
  7. Oligometastatic non-small-cell lung cancer: current treatment strategiesLung Cancer Targets and Therapy · 2016
  8. Radiation-induced esophagitis in lung cancerLung Cancer Targets and Therapy · 2016
  9. Electromagnetic navigation bronchoscopy: clinical utility in the diagnosis of lung cancerLung Cancer Targets and Therapy · 2016
  10. Fatigue in lung cancer patients: symptom burden and management of challengesLung Cancer Targets and Therapy · 2016
  11. High expression of AKR1C1 is associated with proliferation and migration of small-cell lung cancer cellsLung Cancer Targets and Therapy · 2016
  12. Retrospective analysis of outcomes and prognostic factors of chemotherapy for small-cell lung cancerLung Cancer Targets and Therapy · 2016
  13. Monitoring and management of lung cancer patients following curative-intent treatment: clinical utility of 2-deoxy-2-[fluorine-18]fluoro-d-glucose positron emission tomography/computed tomographyLung Cancer Targets and Therapy · 2016
  14. miRNA-21 as a novel therapeutic target in lung cancerLung Cancer Targets and Therapy · 2016
  15. HSP90 as a novel molecular target in non-small-cell lung cancerLung Cancer Targets and Therapy · 2016
  16. Nutrition support and dietary interventions for patients with lung cancer: current insightsLung Cancer Targets and Therapy · 2016
  17. Epiregulin as a therapeutic target in non-small-cell lung cancerLung Cancer Targets and Therapy · 2015
  18. First-line treatment of advanced ALK-positive non-small-cell lung cancerLung Cancer Targets and Therapy · 2015
  19. Targeting PD-1/PD-L1 in lung cancer: current perspectivesLung Cancer Targets and Therapy · 2015
  20. Non-small-cell lung carcinoma: role of the Notch signaling pathwayLung Cancer Targets and Therapy · 2015
  21. AXL receptor tyrosine kinase as a therapeutic target in NSCLCLung Cancer Targets and Therapy · 2015
  22. Hapten-enhanced therapeutic effect in advanced stages of lung cancer by ultra-minimum incision personalized intratumoral chemoimmunotherapy therapyLung Cancer Targets and Therapy · 2015
  23. Pemetrexed in maintenance treatment of advanced non-squamous non-small-cell lung cancerLung Cancer Targets and Therapy · 2015
  24. Staging lung cancer: role of endobronchial ultrasoundLung Cancer Targets and Therapy · 2014
  25. Targeted treatment of mutated EGFR-expressing non-small-cell lung cancer: focus on erlotinib with companion diagnosticsLung Cancer Targets and Therapy · 2014
  26. Clinical potential of nintedanib for the second-line treatment of advanced non-small-cell lung cancer: current evidenceLung Cancer Targets and Therapy · 2014
  27. Profile of bavituximab and its potential in the treatment of non-small-cell lung cancerLung Cancer Targets and Therapy · 2014
  28. New options in the management of intractable ALK(+) metastatic non-small-cell lung cancerLung Cancer Targets and Therapy · 2014
  29. Prevalence of driver mutations in non-small-cell lung cancers in the People’s Republic of ChinaLung Cancer Targets and Therapy · 2014
  30. Gastroesophageal junction adenocarcinoma displays abnormalities in homologous recombination and nucleotide excision repairLung Cancer Targets and Therapy · 2014
  31. Potential toxicity and safety evaluation of nanomaterials for the respiratory system and lung cancerLung Cancer Targets and Therapy · 2013
  32. Emerging treatments in lung cancer – targeting the RLIP76 molecular transporterLung Cancer Targets and Therapy · 2013
  33. Practical management of NSCLC patients with long-term bevacizumab treatment: a report of four casesLung Cancer Targets and Therapy · 2013
  34. Robotic stereotactic body radiation therapy for elderly medically inoperable early-stage non-small cell lung cancerLung Cancer Targets and Therapy · 2013
  35. EGFR mutations in patients with lung adenocarcinoma in southwest China: are G719S/A and L861Q more likely detected in tumors derived from smokers?Lung Cancer Targets and Therapy · 2013
  36. MET overexpression and gene amplification in NSCLC: a clinical perspectiveLung Cancer Targets and Therapy · 2013
  37. Targeted inhibition in tumors with ALK dependencyLung Cancer Targets and Therapy · 2013
  38. Lung cancer in womenLung Cancer Targets and Therapy · 2012
  39. MET targeted therapy for lung cancer: clinical development and future directionsLung Cancer Targets and Therapy · 2012
  40. Economic evaluation of pemetrexed versus erlotinib as second-line treatment of patients with advanced/metastatic non-small cell lung cancer in Greece: a cost minimization analysisLung Cancer Targets and Therapy · 2012
  41. Non-small cell lung cancer: the era of targeted therapyLung Cancer Targets and Therapy · 2012
  42. Update on biomarkers for the detection of lung cancerLung Cancer Targets and Therapy · 2012
  43. A pilot study of a metronomic chemotherapy regimen with weekly low-dose docetaxel for previously treated non-small cell lung cancerLung Cancer Targets and Therapy · 2012
  44. Single nucleotide polymorphisms as susceptibility, prognostic, and therapeutic markers of nonsmall cell lung cancerLung Cancer Targets and Therapy · 2011
  45. Nimotuzumab, a novel monoclonal antibody to the epidermal growth factor receptor, in the treatment of non-small cell lung cancerLung Cancer Targets and Therapy · 2011
  46. Afatinib treatment in advanced non-small cell lung cancerLung Cancer Targets and Therapy · 2011
  47. Effectiveness of maintenance treatments for nonsmall cell lung cancerLung Cancer Targets and Therapy · 2011
  48. Emerging treatment options in the management of non-small cell lung cancerLung Cancer Targets and Therapy · 2011
  49. Dyspnea in lung cancer patients: a systematic reviewLung Cancer Targets and Therapy · 2010
  50. Azacitidine and decitabine have different mechanisms of action in non-small cell lung cancer cell linesLung Cancer Targets and Therapy · 2010